Monday 16 March 2026

The Pharma Letter Podcast — Episode 1 — Belong.Life

Pharmaceutical
Simon Wentworth
13 July 2021
podcast-episode1-1--1

More on this story...

Pharmaceutical
Time for digital marketing of migraine drugs has arrived in Japan
8 July 2021
Pharmaceutical
Manufacturing and marketing approval in Japan for Joyclu
25 March 2021
Pharmaceutical
Exec change at Merck, as Mike Nally quits top marketing job
18 March 2021
Biotechnology
The Pharma Letter Podcast — Episode 4 — The state of biotech investing
1 September 2021




More ones to watch >




Today's issue

Sanofi to supply COVID-19 vaccine for UK booster campaign
Biotechnology
Sanofi to supply COVID-19 vaccine for UK booster campaign
16 March 2026
Pharmaceutical
NCCN recommends Boehringer’s Hernexeos as an initial treatment option
15 March 2026
Pharmaceutical
The week in pharma: action, reaction and insight – week to March 13, 2026
15 March 2026
Biotechnology
Immutep tanks as it discontinues ‘efti’ trial following futility analysis
13 March 2026
Pharmaceutical
Otsuka unveils new repinatrabit data in PKU
13 March 2026
Biotechnology
Purple Biotech’s CEO stepping down
13 March 2026
Pharmaceutical
Bayer in UK code breach over Eylea
13 March 2026


Company Spotlight

Purple Biotech
A clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance.


More Features in Pharmaceutical

NCCN recommends Boehringer’s Hernexeos as an initial treatment option
15 March 2026
The week in pharma: action, reaction and insight – week to March 13, 2026
15 March 2026
Otsuka unveils new repinatrabit data in PKU
13 March 2026
Bayer in UK code breach over Eylea
13 March 2026


Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze